专利检索 ap:("Genentech, Inc.") AND inv:"Ting-Kun Mark Lin" 第 1 页

1.

发明授权
Methods and compositions comprising a KRas 有权

公开(公告)号：US12016862B2

公开(公告)日：2024-06-25

申请号：US17524050

申请日：2021-11-11

申请人： Genentech, Inc.

发明人： Marie Evangelista , Mark Andrew Merchant , Jennifer Lee Schutzman , Ting-Kun Mark Lin , Stephanie Royer Joo , Sandhya Vinayak Mandlekar , Stuart G. Lutzker

IPC分类号： A61P35/00 , A61K31/517 , C07D487/14 , C07K16/22

CPC分类号： A61K31/517 , A61P35/00 , C07K16/22

摘要： Provided herein are combination therapies comprising a KRasG12C inhibitor (e.g. Compound 1 or a pharmaceutically acceptable salt thereof) and a VEGF antagonist (e.g., bevacizumab) and methods of using such combination therapies.

2.

发明申请
METHODS AND COMPOSITIONS COMPRISING A KRASG12C INHIBITOR AND A VEGF INHIBITOR FOR TREATING SOLID TUMORS 有权

公开(公告)号：US20220152030A1

公开(公告)日：2022-05-19

申请号：US17524050

申请日：2021-11-11

申请人： Genentech, Inc.

发明人： Marie Evangelista , Mark Andrew Merchant , Jennifer Lee Schutzman , Ting-Kun Mark Lin , Stephanie Royer Joo , Sandhya Vinayak Mandlekar , Stuart G. Lutzker

IPC分类号： A61K31/517 , A61P35/00 , C07K16/22

摘要： Provided herein are combination therapies comprising a KRasG12C inhibitor (e.g. Compound 1 or a pharmaceutically acceptable salt thereof) and a VEGF antagonist (e.g., bevacizumab) and methods of using such combination therapies.